The VA touted this increase in vaccination as responsible for a decrease in inpatient admissions for pneumonia ( Figure 2 ) (2).
Figure 2. Hospital discharges per 1000 for pneumonia by year (2).
However, what was not cited was that hospital discharges for all groups were decreasing. Furthermore, there was an increase in outpatient visits for pneumonia ( Figure 3 ) (3). An increase in risk-adjusted one year survival occurred for pneumonia from 1994 through 1998 which was less than 1% (p=0.02) (3). However, the improvement in survival did not correlate with the increase in pneumococcal vaccination (r=0.19, p>0.05). Most of the improvement in survival occurred between 1994 and 1995 before the dramatic increase in PPV-23 vaccination rate occurred between 1995 and 1997. It would appear that the reduction in hospital admissions was part of a trend to increase outpatient therapy. There appeared to be no clinically significant impact on the incidence or mortality.
Determinants of hospitalization for pneumonia are many as the above illustrates.
Since the introduction of PCV7 in 2000, there has been a 60% increase in the vaccination of adults 65 years of age or older with pneumococcal polysaccharide vaccine and an increase of 67% in influenza (4) . During this same period, the percentage of adults who smoked fell to 24% (5) . There has been increasing emphasis placed on outpatient therapy for pneumonia with assessment tools such as the pneumonia severity index and CURB-65 (6).
Despite the similarity of arguments for a decline in hospitalizations from PCV7, there is an important difference. There is strong evidence that PCV7 works in children while the efficacy of PPV-23 in adults is suspect (7, 8) . There is considerable year-to-year variability in the incidence of pneumonia with <5% actually diagnosed with pneumococcal disease (1) . The influence of these and other factors such as influenza vaccine and variability in hospital admissions further confuse the issue (9) . It may be that the authors are correct, that PCV7 does prevent pneumonia in adults. However, presenting only the hospital admission rates without accounting for at least some of the many confounding variables makes the overall level of evidence cited in this article unconvincing.
Richard A. Robbins, MD
